低聚壳聚糖与α-丙氨酸/天冬酰胺的美拉德反应及其衍生物的抗氧化性能研究

研究低聚壳聚糖(COS)与α-丙氨酸/天冬酰胺的美拉德反应,考察了两个体系(低聚壳聚糖的羰基与氨基的物质量比均为1∶1)的pH、吸光度和荧光值的变化。醇沉法提取低聚壳聚糖衍生物CA和CN。对两种衍生物进行红外表征和分子量测定,并研究其对超氧阳离子O2-.、DPPH自由基的清除能力以及还原能力。结果显示:抗氧化能力强弱次序为CA>CN>COS,即美拉德反应后低聚壳聚糖衍生物抗氧化能力得到显著提高,且CA的抗氧化活性优于CN,表明与小分子氨基酸进行美拉德反应制得的壳聚糖衍生物具有更好的抗氧化性。     

低聚壳聚糖美拉德衍生物抑菌性能研究

本文研究了基于与葡萄糖、麦芽糖和木糖进行美拉德反应的低聚壳聚糖衍生物的抑菌性.测定低聚壳聚糖及其衍生物对大肠杆菌和金黄色葡萄球菌的抑制效果.结果显示:壳聚糖及其衍生物对金黄色葡萄球菌的抑制作用强于对大肠杆菌的抑制作用,且随着浓度增加,对两种菌的抑菌效果增强.大多数壳聚糖衍生物的抑菌效果优于壳聚糖本身,其中CG 1∶1 8 h(低聚壳聚糖的氨基与葡萄糖的羰基的物质量比为1∶1,反应8h)的抑菌效果最好,CM 1∶3 8 h(低聚壳聚糖的氨基与麦芽糖的羰基的物质量比为1∶3,反应8 h)抑菌性最差,这可能与参加反应的还原糖种类、反应物比例以及反应时间相关.     

不同取代度N-马来酰低聚壳聚糖的抗氧化活性的研究

低聚壳聚糖(COS)酰化得到三种取代度(DS)不同的N-马来酰低聚壳聚糖衍生物NMCOSA、NMCOSB和NMCOSC,其DS分别为0.25、0.67和0.89。对其结构进行红外表征。并考察了NMCOSA、NMCOSB和NMCOSC对羟基自由基(.OH)、1,1-二苯基苦基苯肼(DPPH)的清除活性以及还原能力。结果表明:N-马来酰衍生物有明显的抗氧化活性,随着取代度的升高,N-马来酰衍生物清除DPPH的能力以及还原能力增强,即NMCOSCNMCOSBNMCOSA;清除.OH的活性顺序为NMCOSBNMCOSANMCOSC,即取代度为0.67的表现出最强的活性。这可能与氨基和羟基的数目、取代基团的性质以及清除自由基的机理不同有关。     

人参皂苷Re与精氨酸美拉德反应产物的抗氧化性研究

为了研究人参皂苷Re与精氨酸美拉德反应产物的抗氧化活性,采用人参皂苷Re与精氨酸在100℃反应4 h制备得到美拉德反应产物。HPLC分析产物中人参皂苷Re的结构变化,考察了反应体系的褐变程度,并测试了体系的总多酚含量、Cu~(2+)螯合能力、DPPH自由基清除能力,以及对Cu~(2+)诱导的HepG2细胞的抗氧化作用。结果显示,美拉德反应产物中人参皂苷Re部分转化为Rg2、Rg6和F4,美拉德反应产物的褐变程度、总多酚含量显著增加,与对照相比,美拉德反应产物对Cu~(2+)螯合能力和DPPH自由基清除能力显著提高,100~300μg/m L美拉德反应产物对Cu~(2+)诱导的HepG2细胞氧化应激具有显著的抑制能力。     

N-琥珀酰低聚壳聚糖的抗氧化性能研究(英文)

低聚壳聚糖经化学改性得到三种取代度不同的N-琥珀酰低聚壳聚糖(NSCOSA、NSCOSB和NSCOSC,取代度(DS)分别是为0.25、0.57和0.70。对其结构进行红外表征,并且并考察了其对超氧阴离子自由基(O-·2)、羟基自由基(·OH)、DPPH的清除活性以及还原能力。结果表明:N-琥珀酰低聚壳聚糖衍生物的抗氧化活性与低聚壳聚糖相比有所降低。随着DS的升高,琥珀酰衍生物对·OH的清除能力下降;对O-·2的清除能力大小顺序为NSCBNSCANSCC;对DPPH的清除能力以及还原能力大小顺序均为:NSCANSCCNSCB。这可能是由于N-琥珀酰低聚壳聚糖的取代度、引进基团的性质以及对自由基的清除机理不同所致。     

山楂多糖提取工艺优化及其抗氧化活性研究

目的：优化热水浸提法提取山楂多糖的最佳工艺条件,并研究其结构和体外抗氧化活性。方法：在单因素试验的基础上,以水浴温度、水浴时间、料水比、冷浸时间为因素,通过正交试验设计优化其提取工艺;多糖经纯化后分别采用GPC、GC-MS分析其分子量和单糖组成,并通过对超氧自由、羟自由基、DPPH（1,1-二苯基-2-三硝基苯肼）自由基清除试验测定山楂多糖的抗氧化活性。结果：最佳提取条件为浸提温度90 ℃、浸提时间6 h、料水比1∶20、冷浸时间为13 h,此条件下提取的多糖经过纯化后,其分子量为5.59×104 Da,单糖含量比例（阿拉伯糖∶木糖∶甘露糖∶葡萄糖∶半乳糖）为1∶1∶28∶8∶12。经测定,多糖具有一定的超氧自由基、羟自由基、DPPH自由基体外清除能力,在0.5~2.5 mg/mL的浓度范围内,清除率分别为12.3%~37.9%、12.3%~40.9%、15.3%~42.6%,说明抗氧化活性较好。结论：本研究可为山楂资源的开发利用和山楂多糖的药理研究提供科学依据。     

葡聚糖糖基化处理对绿豆蛋白抗氧化性影响研究

以绿豆分离蛋白（MBPI）和葡聚糖为原料,通过湿热法制备MBPI-Dextran共价复合物。本研究通过测定产物的还原力、DPPH自由基清除能力、超氧阴离子自由基、羟自由基清除能力共同评价糖基化反应对MBPI抗氧化能力的影响。结果表明：MBPI-Dextran共价复合物具有一定的抗氧化能力,特别是90℃条件下反应得到的产物,抗氧化能力较80℃产物显著提升,这与美拉德反应程度有关,较高温度下美拉德反应进程加快,促使更多具有抗氧化能力的物质生成。因此,糖基化改性后的绿豆蛋白在抗氧化能力研究上具有一定的应用价值。     

脱乙酰壳聚糖固定化宇佐美曲霉木聚糖酶及固定化酶的性质和应用(英文)

研究壳聚糖吸附和戊二醛交联对木聚糖酶固定化条件 .将酶液加入到经醋酸溶液处理过的脱乙酰壳聚糖的pH 4 8的悬液中 ,加入浓度为 0 3%～ 0 4 %的戊二醛溶液 ,室温下 ,8h后得到固定化酶 .固定化酶的半失活温度比游离酶高 ,由 5 1℃升至 71℃ ,Km 值由游离酶的 1 2mg ml增加到1 5mg ml ,最适反应温度也由 5 5℃增加到 71℃ ,而最适反应pH由 4 6下降到 3 8.该固定化木聚糖酶可用于制造低聚木糖 .经过 10次连续应用实验后 ,该固定化酶的活力保持 81%     

N-酰化低聚壳聚糖衍生物还原能力的研究

对低聚壳聚糖进行N-酰化改性,制得取代度相同的N-马来酰低聚壳聚糖(NMCOS),N-琥珀酰低聚壳聚糖(NSCOS),N-邻苯二甲酰低聚壳聚糖(NPCOS),其中NMCOS1、NSCOS1、NPCOS1的取代度均为0.25;NMCOS2、NSCOS2、NPCOS2的取代度均为0.49。考察了6种N-酰化低聚壳聚糖衍生物的还原能力。结果表明:当取代度相同时,N-邻苯二甲酰低聚壳聚糖的还原能力最强,其次是N-马来酰低聚壳聚糖,N-琥珀酰低聚壳聚糖的还原能力最差。这可能是由取代基的性质不同所致。     

不同取代度N-邻苯二甲酰壳聚糖抗氧化活性的研究

低聚壳聚糖与邻苯二甲酸酐酰化得到三种取代度不同的N-邻苯二甲酸酐酰低聚壳聚糖NPCOSA、NPCOSB和NPCOSC,取代度分别为0.330、.55和0.65。通过红外光谱对其结构进行表征。并考察了其抗氧化性能。结果表明:COS的抗氧化性能最强;随着取代度的增加,N-邻苯二甲酰低聚壳聚糖对超氧阴离子的清除能力逐渐升高;而对DPPH的清除能力以及还原能力呈逐渐下降趋势;对羟基自由基的清除顺序大小依次为NPCOSB>NPCOSA>NPCOSC,即NPCOSB清除羟基自由基的的能力最佳。     

Obtaining and study of monosaccharide derivatives of low-molecular-weight chitosan

The possibility of obtaining monosaccharide derivatives of low-molecular-weight chitosan with the use of the Maillard reaction was studied. Chitosan derivatives (molecular weight, 24 and 5 kDa) obtained with glucosamine, N-acetyl galactosamine, galactose, and mannose with a substitution degree of 4-14% and a yield of 60-80% were obtained. Some physicochemical and biological properties of these derivatives were studied. We showed that monosaccharide derivatives of low-molecular-weight chitosan exhibited antibacterial activity. Chitosan at a concentration of 0.01% caused 100% death of bacteria B. subtilis and E. coil. The strongest antibacterial effect was exhibited by 24-kDa derivatives: only 0.02-0.08% of cells survived. These derivatives were two orders of magnitude more effective than the 5-kDa chitosan modified with galactose.     

The preparation and antioxidant activity of the sulfanilamide derivatives of chitosan and chitosan sulfates

Chitosan (CS) and chitosan sulfates (CSS) with different molecular weight (Mw) were reacted with 4-acetamidobenzene sulfonyl chloride to obtain sulfanilamide derivatives of chitosan and chitosan sulfates (LSACS, HSACS, LSACSS, HSACSS). The preparation conditions such as different reaction time, temperature, solvent, and the molar ratio of reaction materials are discussed in this paper. Their structures were characterized by FTIR spectroscopy and elemental analyses. The antioxidant activities of the derivatives were investigated employing various established in vitro systems, such as hydroxyl-radical ((*)OH) superoxide anion (O2(*-)) scavenging and reducing power. All kinds of the compounds (HCS, LCS, HCSS, LCSS, HSACS, LSACS, HSACSS, LSACSS) showed stronger scavenging activity on hydroxyl radical than ascorbic acid (Vc). The inhibitory activities of the derivatives toward superoxide radical by the PMS-NADH system were obvious. The experiment showed that the superoxide radical scavenging effect of sulfanilamide derivatives of chitosan and chitosan sulfates was stronger than that of original CS and CSS. All of the derivatives were efficient in the reducing power. The results indicated that the sulfanilamide group were grafted on CS and CSS increased the reducing power of them obviously.     

Obtaining and study of monosaccharide derivatives of low-molecular-weight chitosan

The possibility of obtaining monosaccharide derivatives of low-molecular-weight chitosan with the use of the Maillard reaction was studied. Chitosan derivatives (molecular weight, 24 and 5 kDa) obtained with glucosamine, N-acetyl galactosamine, galactose, and mannose with a substitution degree of 4–14% and a yield of 60–80% were obtained. Some physicochemical and biological properties of these derivatives were studied. We showed that monosaccharide derivatives of low-molecular-weight chitosan exhibited antibacterial activity. Chitosan at a concentration of 0.01% caused 100% death of bacteria B. subtilis and E. coli. The strongest antibacterial effect was exhibited by 24-kDa derivatives: only 0.02–0.08% of cells survived. These derivatives were two orders of magnitude more effective than the 5-kDa chitosan modified with galactose.     

Synthesis, characterization, and antifungal activity of novel quaternary chitosan derivatives

Three novel quaternary chitosan derivatives were successfully synthesized by reaction of chloracetyl chitosan (CACS) with pyridine (PACS), 4-(5-chloro-2-hydroxybenzylideneamino)-pyridine (CHPACS), and 4-(5-bromo-2-hydroxybenzylideneamino)-pyridine (BHPACS). The chemical structure of the prepared chitosan derivatives was confirmed by Fourier transform infrared (FT-IR) and ¹³C nuclear magnetic resonance (¹³C NMR) and their antifungal activity against Cladosporium cucumerinum, Monilinia fructicola, Colletotrichum lagenarium, and Fusarium oxysporum was assessed. Comparing with the antifungal activity of chitosan, CACS, and PACS, CHPACS and BHPACS exhibited obviously better inhibitory effects, which should be related to the synergistic reaction of chitosan itself with the grafted 2-[4-(5-chloro-2-hydroxybenzylideneamino)-pyridyl]acetyl and 2-[4-(5-bromo-2-hydroxybenzylideneamino)-pyridyl]acetyl.     

Hydroxyl radicals scavenging activity of N-substituted chitosan and quaternized chitosan

N-substituted chitosan and quaternized chitosan were synthesized and their antioxidant activity against hydroxyl radicals was assessed, respectively. Compared with the antioxidant activity of chitosan, the results indicated that the two kinds of chitosan derivatives had different scavenging ability on hydroxyl radicals, which should be related to the form of amido in the two kinds of chitosan derivatives.     

NMR investigation of chitosan derivatives formed by the reaction of chitosan with levulinic acid

Chitosan derivatives are obtained by reaction of chitosan with a low degree of acetylation and levulinic acid under different experimental conditions. The chemical structure of the different derivatives obtained is determined using ¹H and ¹³C NMR spectroscopies. The intrinsic viscosity is used to follow the molecular weight evolution. Finally, conditions are described in which water-soluble N-carboxybutylchitosan is obtained. In particular, the time of the reduction step and the ratio between reagents are investigated. Under mild conditions and short times of reduction there is a very low degree of substitution and only the monocarboxybutylchitosan is formed. The dicarboxylated form is never observed. The cyclic derivative (5-methylpyrrolidinone chitosan) is obtained when the reducing agent is added slowly to the reactants.     

绿色木霉粗纤维素酶液水解壳聚糖的研究

利用自制绿色木霉粗纤维素酶液降解壳聚糖制备低聚壳聚糖.采用粘度法、乙酰丙酮法和还原糖浓度分析,研究了温度、pH值及反应时间等因素对壳聚糖水解程度和产物相对分子质量的影响,并采用质谱法对水解产物进行定性分析.结果表明,粗纤维素酶液水解壳聚糖作用的最适pH为5.0、最适反应温度为50 ℃、最适反应时间为12 h.粗纤维素酶...     

Molecular weight and pH effects of aminoethyl modified chitosan on antibacterial activity in vitro

Aminoethyl modified chitosan derivatives (AEMCSs) with different molecular weight (Mw) were synthesized by grafting aminoethyl group on different molecular weight chitosans and chitooligosaccharide. FTIR, (1)H NMR, (13)C NMR, elemental analysis and potentiometric titration results showed that branched polyethylimine chitosan was synthesized. Clinical Laboratory Standard Institute (CLSI) protocols were used to determine MIC for Gram-negative strain of Escherichia coli under different pH. The antibacterial activity of the derivatives was significantly improved compared with original chitosans, with MIC values against E. coli varying from 4 to 64 μg/mL depending on different Mw and pH. High molecular weight seems to be in favor of stronger antibacterial activity. At pH 7.4, derivatives with Mw above 27 kDa exhibited equivalent antibacterial activity (16 μg/mL), while oligosaccharide chitosan derivative with lower Mw (~1.4 kDa) showed decreased MIC of 64 μg/mL. The effect of pH on antibacterial activity is more complicated. An optimal pH for HAEMCS was found around 6.5 to give MIC as low as 4 μg/mL, while higher or lower pH compromised the activity. Cell integrity assay and SEM images showed evident cell disruption, indicating membrane disruption may be one possible mechanism for antibacterial activity.